Ovid Therapeutics Inc (OVID)

Jun 17, 2025

Balance Sheet Insights: Ovid Therapeutics Inc (OVID)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Jun 17, 2025

Jun 13, 2025

Ovid Therapeutics Inc (OVID) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jun 13, 2025

Jun 13, 2025

Rising Leaders 2025: Ovid’s Meg Alexander On Neurology’s Next Frontier - insights.citeline.com

Jun 13, 2025

Jun 12, 2025

Transcript : Ovid Therapeutics Inc.Special Call - marketscreener.com

Jun 12, 2025

Jun 11, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jun 11, 2025

Jun 09, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results - mx.advfn.com

Jun 09, 2025

Jun 05, 2025

Ovid Therapeutics (OVID) to Showcase Biomarker Advances in Epile - GuruFocus

Jun 05, 2025

Jun 05, 2025

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025 | OVID Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025 - GlobeNewswire

Jun 05, 2025

Jun 05, 2025

Harvard Expert to Present Breakthrough Epilepsy Treatment Data at Ovid Therapeutics Event - Stock Titan

Jun 05, 2025

Jun 01, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 01, 2025

May 30, 2025

HC Wainwright Predicts Weaker Earnings for Ovid Therapeutics - Defense World

May 30, 2025

May 28, 2025

Ovid Therapeutics (NASDAQ:OVID) Price Target Cut to $1.50 by Analysts at HC Wainwright - Defense World

May 28, 2025

May 28, 2025

Ovid Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 28, 2025

May 27, 2025

Ovid Therapeutics (OVID): HC Wainwright & Co. Lowers Price Targe - GuruFocus

May 27, 2025

May 27, 2025

Ovid Therapeutics (OVID): Price Target Revised Amid Future Growt - GuruFocus

May 27, 2025

May 27, 2025

Ovid Therapeutics (OVID): Price Target Revised Amid Future Growth Prospects | OVID Stock News - GuruFocus

May 27, 2025

May 27, 2025

H.C. Wainwright cuts Ovid stock price target to $1.50, keeps buy rating - Investing.com

May 27, 2025

May 20, 2025

Brokerages Set Ovid Therapeutics Inc. (NASDAQ:OVID) PT at $3.03 - Defense World

May 20, 2025

May 19, 2025

What is B. Riley’s Forecast for OVID Q2 Earnings? - Defense World

May 19, 2025

May 18, 2025

Q3 EPS Estimate for Ovid Therapeutics Raised by Analyst - Defense World

May 18, 2025

May 17, 2025

Wedbush Decreases Earnings Estimates for Ovid Therapeutics - Defense World

May 17, 2025

May 16, 2025

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Ovid Therapeutics (OVID) - The Globe and Mail

May 16, 2025

May 13, 2025

Ovid Therapeutics (OVID) Exceeds Q1 Revenue Expectations and Adv - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics (OVID) Reports $43 Million in Cash Reserves | - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 202 - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 13, 2025

May 13, 2025

Ovid Therapeutics Inc Reports Q1 2025 EPS of -$0.14, Meeting Est - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results | OVID Stock News - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics (OVID) Reports $43 Million in Cash Reserves | OVID Stock News - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics Inc. SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025

May 11, 2025

Ovid Therapeutics (OVID) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 08, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Shares Purchased by Renaissance Technologies LLC - Defense World

May 08, 2025

May 06, 2025

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 06, 2025

May 05, 2025

Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results - ADVFN

May 05, 2025

May 05, 2025

Dup15q syndrome Market: Epidemiology, Therapies, Companies, - openPR.com

May 05, 2025

Apr 27, 2025

JPMorgan Chase & Co. Decreases Stock Holdings in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World

Apr 27, 2025

Apr 27, 2025

Ovid Therapeutics (NASDAQ:OVID) Upgraded at William Blair - Defense World

Apr 27, 2025

Apr 25, 2025

Analysts Set Ovid Therapeutics Inc. (NASDAQ:OVID) Target Price at $3.03 - Defense World

Apr 25, 2025

Apr 24, 2025

Ovid Therapeutics Inc [OVID] stock for 2,956 USD was sold by ALEXANDER MARGARET A. - knoxdaily.com

Apr 24, 2025

Apr 24, 2025

The OVID Stock Puzzle: Unraveling Ovid Therapeutics Inc’s Fluctuating Performance - investchronicle.com

Apr 24, 2025

Apr 24, 2025

A closer look at Ovid Therapeutics Inc (OVID) is warranted - uspostnews.com

Apr 24, 2025

Apr 20, 2025

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium | Libero Quotidiano.it - Libero Quotidiano

Apr 20, 2025

Apr 18, 2025

Dravet Syndrome Treatment Market Future Business - openPR.com

Apr 18, 2025

Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025

Apr 07, 2025

Ovid Therapeutics stock hits 52-week low at $0.27 By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Ovid Therapeutics stock hits 52-week low at $0.27 - Investing.com

Apr 07, 2025